Selection of patients for radiotherapy with protons aiming at reduction of side effects: The model-based approach

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 267-273

  Langendijk, Johannes A ^a   Lambin, Philippe ^b   De Ruysscher, Dirk ^c   Widder, Joachim ^a   Bos, Mike ^d   Verheij, Marcel ^e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Social and Economic Council of The Netherlands   (Netherlands)

^e NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

NTCP models; Patient selection; Proton therapy; Randomisation

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; ESOPHAGITIS; FOLLOW UP; HUMAN; HYPOSALIVATION; INTENSITY MODULATED RADIATION THERAPY; MORBIDITY; OBSERVATIONAL STUDY; PATIENT SELECTION; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONIA; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT PLANNING; XEROSTOMIA;

NTCP-MODELS; PATIENT SELECTION; PROTON THERAPY; RANDOMISATION;

HUMANS; PATIENT SELECTION; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84881478145     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.05.007     Document Type: Review

References (43)

1. J.A. Langendijk, P. Doornaert, I.M. Verdonck-de Leeuw, C.R. Leemans, N.K. Aaronson, and B.J. Slotman Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy J Clin Oncol 26 2008 3770 3776
2. E. Mrozek, and C.L. Shapiro Survivorship and complications of treatment in breast cancer Clin Adv Hematol Oncol 3 211-22 2005 238 Review
3. S. Egawa, S. Shimura, and A. Irie Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer Jpn J Clin Oncol 31 2001 541 547
4. A. Murata, C.J. Brown, M. Raval, and P.T. Phang Impact of short-course radiotherapy and low anterior resection on quality of life and bowel function in primary rectal cancer Am J Surg 195 2008 611 615
5. K. Jensen, A. Bonde Jensen, and C. Grau The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires Radiother Oncol 78 2006 298 305
6. K.R. Trott, W. Doerr, and A. Facoetti Biological mechanisms of normal tissue damage: importance for the design of NTCP models Radiother Oncol 105 2012 79 85
7. J.O. Deasy, V. Moiseenko, L. Marks, K.S. Chao, J. Nam, and A. Eisbruch Radiotherapy dose-volume effects on salivary gland function Int J Radiat Oncol Biol Phys 76 Suppl. 3 2010 S58 S63
8. M. Werner-Wasik, E. Yorke, J. Deasy, J. Nam, and L.B. Marks Radiation dose-volume effects in the esophagus Int J Radiat Oncol Biol Phys 76 2010 S86 S93
9. G. Gagliardi, L.S. Constine, V. Moiseenko, C. Correa, L.J. Pierce, and A.M. Allen Radiation dose-volume effects in the heart Int J Radiat Oncol Biol Phys 76 2010 S77 S85
10. T. Rancati, M. Schwarz, A.M. Allen, F. Feng, A. Popovtzer, and B. Mittal Radiation dose-volume effects in the larynx and pharynx Int J Radiat Oncol Biol Phys 76 2010 S64 S69
11. L.B. Marks, S.M. Bentzen, and J.O. Deasy Radiation dose-volume effects in the lung Int J Radiat Oncol Biol Phys 76 2010 S70 S76
12. J.M. Michalski, H. Gay, A. Jackson, S.L. Tucker, and J.O. Deasy Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
13. M. Stuschke, A. Kaiser, C. Pöttgen, W. Lübcke, and J. Farr Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans Radiother Oncol 104 2012 45 51
14. J.A. Efstathiou, J.J. Paly, and H.M. Lu Adjuvant radiation therapy for early stage seminoma: proton versus photon planning comparison and modeling of second cancer risk Radiother Oncol 103 2012 12 17
15. H.A. Wolff, D.M. Wagner, and L.C. Conradi Irradiation with protons for the individualized treatment of patients with locally advanced rectal cancer: a planning study with clinical implications Radiother Oncol 102 2012 30 37
16. M. Schwarz, A. Pierelli, and C. Fiorino Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison Radiother Oncol 98 2011 74 80
17. S.H. Moon, K.H. Shin, and T.H. Kim Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy Radiother Oncol 90 2009 66 73
18. H.P. van der Laan, and T.A. van de Water Rococo cooperative group. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study Acta Oncol 52 2013 561 569
19. T.A. Van de Water, H.P. Bijl, C. Schilstra, M. Pijls-Johannesma, and J.A. Langendijk The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature Oncologist 16 2011 366 377
20. T.A. Van de Water, A.J. Lomax, and H.P. Bijl Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer Int J Radiat Oncol Biol Phys 79 2011 1216 1224
21. E. Roelofs, M. Engelsman, and C. Rasch ROCOCO Consortium. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer J Thorac Oncol 7 2012 165 176
22. E. Roelofs, L. Persoon, and S. Qamhiyeh Design of and technical challenges involved in a framework for multicentric radiotherapy treatment planning studies Radiother Oncol 97 2010 567 571
23. B.M. Aleman, A.W. van den Belt-Dusebout, W.J. Klokman, M.B. Van't Veer, H. Bartelink, and F.E. van Leeuwen Long-term cause-specific mortality of patients treated for Hodgkin's disease J Clin Oncol 21 2003 3431 3439
24. S.C. Darby, M. Ewertz, and P. McGale Risk of ischemic heart disease in women after radiotherapy for breast cancer N Engl J Med 368 2013 987 998
25. K.E. Henson, P. McGale, C. Taylor, and S.C. Darby Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer Br J Cancer 108 2013 179 182
26. S.M. Bentzen Randomized controlled trials in health technology assessment: overkill or overdue? Radiother Oncol 86 2008 142 147
27. M.E. Christianen, C. Schilstra, and I. Beetz Predictive modelling for swallowing dysfunction after primary (chemo) radiation: results of a prospective observational study Radiother Oncol 105 2012 107 114
28. A.G. Egelmeer, E.R. Velazquez, and J.M. de Jong Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients Radiother Oncol 100 2011 108 115
29. C. Dehing-Oberije, D. De Ruysscher, and S. Petit Development, external validation and clinical usefulness of a practical prediction model for radiation-induced dysphagia in lung cancer patients Radiother Oncol 97 2010 455 461
30. S.T. Peeters, M.S. Hoogeman, W.D. Heemsbergen, A.A. Hart, P.C. Koper, and J.V. Lebesque Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling Int J Radiat Oncol Biol Phys 66 2006 11 19
31. D. De Ruysscher, J. Van Meerbeeck, and K. Vandecasteele Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor? Strahlenther Onkol 188 2012 564 567
32. I. Beetz, C. Schilstra, and A. van der Schaaf NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors Radiother Oncol 105 2012 101 106
33. I. Beetz, C. Schilstra, and P. van Luijk External validation of three dimensional conformal radiotherapy based NTCP models for patient-rated xerostomia and sticky saliva among patients treated with intensity modulated radiotherapy Radiother Oncol 105 2012 94 100
34. I. Beetz, C. Schilstra, and F.R. Burlage Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors Radiother Oncol 105 2012 86 93
35. M.R. Vergeer, P.A. Doornaert, D.H. Rietveld, C.R. Leemans, B.J. Slotman, and J.A. Langendijk Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program Int J Radiat Oncol Biol Phys 74 2009 1 8
36. C.M. Nutting, J.P. Morden, and K.J. Harrington PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
37. W. van Elmpt, M. Öllers, P. Lambin, and D. De Ruysscher Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging Int J Radiat Oncol Biol Phys 82 2012 379 385
38. D.L. Schwartz, A.S. Garden, and S.J. Shah Adaptive radiotherapy for head and neck cancer-dosimetric results from a prospective clinical trial Radiother Oncol 106 2013 80 84
39. S.E. McGowan, N.G. Burnet, and A.J. Lomax Treatment planning optimisation in proton therapy Br J Radiol 86 2013 255545
40. A.J. Lomax Intensity modulated proton therapy and its sensitivity to treatment uncertainties 2: the potential effects of inter-fraction and inter-field motions Phys Med Biol 53 2008 1043 1056
41. A.J. Lomax Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties Phys Med Biol 53 2008 1027 1042
42. J. Unkelbach, T. Bortfeld, B.C. Martin, and M. Soukup Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning Med Phys 36 2009 149 163
43. P. Pommier, Y. Lievens, F. Feschet, J.M. Borras, M.H. Baron, and A. Shtiliyanova Simulating demand for innovative radiotherapies: an illustrative model based on carbon ion and proton radiotherapy Radiother Oncol 96 2010 243 249